Adhesion promoter compositions for cyclic olefin resin compositions

1. A method for improving the adhesion of a resin composition to a substrate material, comprising combining at least one cyclic olefin, at least one olefin metathesis catalyst, and at least one adhesion promoter composition to form a resin composition, contacting the resin composition with the substrate material, and subjecting the resin composition to conditions effective to promote an olefin metathesis reaction of the cyclic olefin,

wherein the at least one adhesion promoter composition comprises a pre-reacted mixture of at least one compound containing at least two isocyanate groups and at least one compound comprising at least one heteroatom-containing functional group and at least one metathesis active olefin,

wherein the at least one compound containing at least two isocyanate groups is 4,4′-methylene diphenyl diisocyanate (MDI) and the at least one compound comprising at least one heteroatom containing functional group and at least one metathesis active olefin is 2-hydroxyethyl bicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB),

wherein the concentration of the at least one adhesion promoter is 2 to 4 phr.

2. The method according to claim 1 , wherein the at least one adhesion promoter composition is storage stable.

3. The method according to claim 2 , wherein the at least one adhesion promoter composition is in-resin storage stable.

4. The method according to claim 1 , wherein the substrate material is a glass substrate, or a carbon substrate.

5. The method according to claim 1 , wherein the pre-reacted mixture of 2-hydroxyethyl bicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB) and 4,4′-methylene diphenyl diisocyanate (MDI) comprises

6. The method according to claim 1 , wherein the at least one olefin metathesis catalyst, is a Group 8 transition metal complex having the structure of Formula (I):

wherein

M is a Group 8 transition metal selected from ruthenium and osmium;

L 1 , L 2 , and L 3 are neutral electron donor ligands;

n is 0 or 1, such that L 3 may or may not be present;

m is 0, 1, or 2;

k is 0 or 1;

X 1 and X 2 are anionic ligands; and

R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups,

wherein any two or more of X 1 , X 2 , L 1 , L 2 , L 3 , R 1 , and R 2 can be taken together to form one or more cyclic groups.

7. The method according to claim 6 , wherein the at least one of L 1 , L 2 , and L 3 is an N-heterocyclic carbene ligand.

8. The method according to claim 7 , wherein the N-heterocyclic carbene ligand has the structure

wherein,

Q is —CR 11 R 12 —CR 13 R 14 — or —CR 11 ═CR 13 —, wherein R 11 , R 12 , R 13 , and R 14 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups, or wherein any two of R 11 , R 12 , R 13 , and R 14 may be linked together to form a substituted or unsubstituted, saturated or unsaturated ring; and

R 3 and R 4 are unsubstituted phenyl or phenyl substituted with one or more substituents selected from C 1 -C 20 alkyl, substituted C 1 -C 20 alkyl, C 1 -C 20 heteroalkyl, substituted C 1 -C 20 heteroalkyl, C 5 -C 24 aryl, substituted C 5 -C 24 aryl, C 5 -C 24 heteroaryl, C 6 -C 24 aralkyl, C 6 -C 24 alkaryl, or halide.

9. The method according to claim 1 , wherein the at least one olefin metathesis catalyst, is a Group 8 transition metal complex having the structure of Formula (VII), wherein:

M is ruthenium;

X 1 and X 2 are anionic ligands;

L 1 is a neutral electron donor ligand;

Y is a heteroatom selected from N, O, S, and P;

R 5 , R 6 , R 7 , and R 8 are each, independently, selected from the group consisting of hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, and borate;

n is 0, 1, or 2, such that n is 1 for the divalent heteroatoms O or S, and n is 2 for the trivalent heteroatoms N or P; and

Z is a group selected from hydrogen, alkyl, aryl, functionalized alkyl, functionalized aryl where the functional group(s) may independently be one or more or the following: alkoxy, aryloxy, halogen, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate, silane, siloxane, phosphine, phosphate, or borate; methyl, isopropyl, sec-butyl, t-butyl, neopentyl, benzyl, phenyl and trimethylsilyl.

10. The method according to claim 1 , wherein the at least one olefin metathesis catalyst has the structure of Formula (I):

wherein:

M is ruthenium;

n is 0;

m is 0;

k is 1;

L 1 and L 2 are trisubstituted phosphines independently selected from the group consisting of tri-n-butylphosphine (Pn-Bu 3 ), tricyclopentylphosphine (PCp 3 ), tricyclohexylphosphine (PCy 3 ), triisopropylphosphine (P-i-Pr 3 ), triphenylphosphine (PPh 3 ), methyldiphenylphosphine (PMePh 2 ), dimethylphenylphosphine (PMe 2 Ph), and diethylphenylphosphine (PEt 2 Ph); or L 1 is an N-heterocyclic carbene selected from the group consisting of 1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene, 1,3-bis(2,4,6-trimethylphenyl)imidazol 2 ylidene, 1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and 1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene and L 2 is a trisubstituted phosphine selected from the group consisting of tri-n-butylphosphine (Pn-Bu 3 ), tricyclopentylphosphine (PCp 3 ), tricyclohexylphosphine (PCy 3 ), triisopropylphosphine (P-i-Pr 3 ), triphenylphosphine (PPh 3 ), methyldiphenylphosphine (PMePh 2 ), dimethylphenylphosphine (PMe 2 Ph), and diethylphenylphosphine (PEt 2 Ph);

L 3 is not present;

X 1 and X 2 are chloride; and

R 1 is hydrogen and R 2 is phenyl or —CH═C(CH 3 ) 2 or thienyl; or R 1 and R 2 are taken together to form phenylindenylidene.

11. The method according to claim 1 , wherein the at least one olefin metathesis catalyst has the structure of Formula (I):

wherein:

M is ruthenium;

n is 0;

m is 0;

k is 1;

L 1 is an N-heterocyclic carbene selected from the group consisting of 1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L 2 is a trisubstituted phosphine independently selected from the group consisting of tri-n-butylphosphine (Pn-Bu 3 ), tricyclopentylphosphine (PCp 3 )tricyclohexylphosphine (PCy 3 ), triisopropylphosphine (P-i-Pr 3 ), triphenylphosphine (PPh 3 ), methyldiphenylphosphine (PMePh2), dimethylphenylphosphine (PMe2Ph), and diethylphenylphosphine (PEt 2 Ph);

L 3 is not present;

X 1 and X 2 are chloride; and

R 1 is hydrogen and R 2 is phenyl or —CH═C(CH 3 ) 2 or thienyl; or R 1 and R 2 are taken together to form phenylindenylidene.

12. The method according to claim 1 , wherein the cyclic olefin is selected from the group consisting of dicyclopentadiene; tricyclopentadiene; cyclopentadiene tetramer; cyclopentadiene pentamer; dicyclohexadiene; norbornene; 5-methyl-2-norbornene; 5-ethyl-2-norbornene; 5-isobutyl-2-norbornene; 5,6-dimethyl-2-norbornene; 5-phenylnorbornene; 5-benzylnorbornene; 5-acetylnorbornene; 5-methoxycarbonylnorbornene; 5-ethoxycarbonyl-1-norbornene; 5-methyl-5-methoxy-carbonylnorbornene; 5-cyanonorbornene; 5,5,6-trim ethyl-2-norbornene; cyclo-hexenylnorbornene; endo, exo-5,6-dimethoxynorbornene; endo, endo-5,6-dimethoxynorbornene; endo, exo-5-6-dimethoxycarbonylnorbornene; endo, endo-5,6-dimethoxycarbonylnorbornene; 2,3-dimethoxynorbornene; norbornadiene; tricycloundecene; tetracyclododecene; 8-methyltetracyclododecene; 8-ethyl-tetracyclododecene; 8-methoxycarbonyltetracyclododecene; 8-methyl-8-tetracyclo-dodecene; 8-cyanotetracyclododecene; pentacyclopentadecene; pentacyclohexadecene; 5-butyl-2-norbornene; 5-hexyl-2-norbornene; 5-octyl-2-norbornene; 5-decyl-2-norbornene; 5-dodecyl-2-norbornene; 5-vinyl-2-norbornene; 5-ethylidene-2-norbornene; 5-isopropenyl-2-norbornene; 5-propenyl-2-norbornene; and 5-butenyl-2-norbornene.

13. The method according to claim 1 , wherein the cyclic olefin is selected from the group consisting of dicyclopentadiene; tricyclopentadiene; cyclopentadiene tetramer; cyclopentadiene pentamer; tetracyclododecene; norbornene; 5-butyl-2-norbornene; 5-hexyl-2-norbornene; 5-octyl-2-norbornene; 5-decyl-2-norbornene; 5-dodecyl-2-norbornene; 5-vinyl-2-norbornene; 5-ethylidene-2-norbornene; 5-isopropenyl-2-norbornene; 5-propenyl-2-norbornene; and 5-butenyl-2-norbornene.

14. The method according to claim 1 , wherein the resin composition further comprises at least one additive.

15. The method according to claim 1 , wherein the resin composition further comprises at least one crosslinker.

16. The method according to claim 15 , wherein the at least one crosslinker is selected from the group consisting of dialkyl peroxides, diacyl peroxides, peroxyacids, and mixtures thereof.